Literature DB >> 1376792

Spare receptors for beta-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart.

L Brown1, N M Deighton, S Bals, W Söhlmann, H R Zerkowski, M C Michel, O E Brodde.   

Abstract

We studied whether the human heart has spare receptors for beta-adrenoceptor-mediated positive inotropic effects. Thus, we assessed in right atria and left papillary muscles of patients with different degrees of heart failure under identical experimental conditions affinity (pKI values from (-)-[125I]iodocyanopindolol binding) and potency (pD2 values from contractile responses) for isoprenaline, adrenaline, and noradrenaline in comparison with rat heart. Plots of beta-adrenoceptor occupancy versus responses constructed from these data revealed that rat left atria and papillary muscles had a large receptor reserve for all three beta-adrenoceptor agonists: 50% of maximal response was produced with only 1-3% of beta-adrenoceptor occupancy. In human heart, however, receptor reserve was considerably lower: 50% of maximal response required 8-10% (in right atria) and 20-25% (in left papillary muscles) occupation of beta-adrenoceptors. Receptor reserve declined further with an increasing degree of heart failure (and decreasing beta-adrenoceptor number): in end-stage heart failure (New York Heart Association class IV) both in right atria and left papillary muscles a 1:1 ratio between beta-adrenoceptor occupancy and responses was observed. These data show that the human heart has only a small receptor reserve for beta-adrenoceptor agonists. This may explain why a decrease in beta-adrenoceptor number leads to a decrease in beta-adrenoceptor function early in the development of heart failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1376792     DOI: 10.1097/00005344-199202000-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  20 in total

1.  Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.

Authors:  Richard M de Jong; Antoon T M Willemsen; Riemer H J A Slart; Paul K Blanksma; Aren van Waarde; Jan Hein Cornel; Willem Vaalburg; Dirk J van Veldhuisen; Philip H Elsinga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-11       Impact factor: 9.236

Review 2.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

Review 3.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

Review 4.  β3 -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Authors:  Yasuhiko Igawa; Naoki Aizawa; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-05-03       Impact factor: 8.739

Review 5.  Tools to study beta3-adrenoceptors.

Authors:  Wim Vrydag; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

6.  Evaluation of cardiac beta 1-adrenergic sensitivity with dobutamine in healthy volunteers.

Authors:  F Pousset; S Chalon; P Thomaré; B Diquet; P Lechat
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

7.  Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion.

Authors:  L McMartin; R J Summers
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.

Authors:  A Hoey; C Jackson; G Pegg; M Sillence
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

9.  beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current.

Authors:  V Arvydas Skeberdis; Vida Gendviliene; Danguole Zablockaite; Rimantas Treinys; Regina Macianskiene; Andrius Bogdelis; Jonas Jurevicius; Rodolphe Fischmeister
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

Authors:  M R Bristow; W A Minobe; M V Raynolds; J D Port; R Rasmussen; P E Ray; A M Feldman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.